GlassScriptPhysician profile
Michelle Dang
NPI 1255999181
$1,502.79
in general payments reported to CMS, 2019-2025
9 companies · $851 in 2025
The $851 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $652 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $287.00 | 2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $254.85 | 2024-2025 | Caplyta |
| Abbvie INC. | $243.19 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $240.27 | 2025 | Cobenfy |
| Moximed, INC | $170.07 | 2025 | Misha Knee System, Small, Left |
| Endo USA, INC. | $154.90 | 2024 | Xiaflex |
| Alkermes, INC. | $80.21 | 2024 | Aristada, Lybalvi |
| Ucb, INC. | $40.50 | 2025 | Bimzelx |
| Kerecis Limited | $31.80 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.